Idéal Investisseur
Français English
CAC 40 : Market open
8 082,68 pts
-0.43%


Last updated : 15/09/2026 - 16h58
🏠 Home   ➤    Stock news

DBV Technologies Stock Rebounds Nearly 4% and Crosses its MM20

In mid-morning trading, the French biotech company regains ground, moving against the trend of a slightly declining SBF 120. The stock is among the largest gains in the broad index, after several weeks of sliding that had brought it down to its technical supports.


DBV Technologies Stock Rebounds Nearly 4% and Crosses its MM20

The stock remains above its MM20 at €2.91 and ranks among the top gains of the SBF 120

DBV Technologies' stock is up 3.9% at €2.99 during the session, among the highest gains in the SBF 120 while the index is down 0.23%. The rebound brings the price just above the 20-day moving average (€2.91), crossed after several sessions below this threshold. However, medium-term benchmarks remain out of reach: the MM50 at €3.20 is still 6.69% above the current price, and the MM200 at €3.07 remains 2.74% above. The RSI at 43 indicates a still neutral dynamic, without signs of excess. Today's movement mitigates the monthly decline of 7.38% and that of 15.65% over three months, but the performance over one year remains largely positive, at nearly 94%. The €2.75 support, broken during the last closing, has not been retested since, with the stock now moving away from this area. The next resistance is at €3.36, a level that has capped the stock since spring.

Short positions increase to 3.45% of capital, amid dual listing on Paris-Nasdaq

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
Before 9 AM every morning Euronext data AI-powered analysis

According to reviewed declarations, three funds cumulatively hold 3.45% of the capital sold short, an increase of 0.55 points over thirty days (from 2.90% a month ago). This level, higher than the 3% threshold generally considered significant, reflects the continued bearish positioning of institutional investors on the stock, in a context of prolonged price slide. The month-over-month increase is moderate and does not suggest a sudden acceleration of distrust, but this point will need to be monitored in upcoming declarations. DBV Technologies remains listed on both Euronext Paris and the Nasdaq via ADS (1 ADS for 5 ordinary shares since November 2024), with Paris remaining the most liquid market despite the dual listing. The stock also joined the Euronext Tech Leaders index on June 22. The next technical milestone to watch remains the sustained crossing of the MM200 at €3.07, which would pave the way towards the resistance zone of €3.36.



Sector Pharmacie et biotechnologies Biotechnologies


Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext

Context

Period
  • Period: S1 2026
Key reported figures
  • Revenue: 1,6 millions de dollars
  • Quarterly revenue: 1,6 millions de dollars
  • Net income: -98 millions de dollars
Guidance from the release
  • DBV is a late-stage biopharmaceutical company currently in regulatory discussions with the FDA, with BLA submission anticipated in Q3 2026; the company reports cash funding into Q3 2027, indicating reliance on capital reserves and no current revenue generation.

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours sur les valeurs Euronext, chaque matin avant 9h.
tendance · 6 séances
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours